Read more
Driven by a constant desire for improvement and development, we reaffirm our commitment to continuous innovation to support veterinarians in their daily practice. This commitment to innovation is part of a sustainable approach: offering reliable, science-based therapeutic solutions adapted to real-world situations.
After more than ten years of absence, we are proud to make the return of Adequan 500 mg/5ml Solution for Injection to the European market. This treatment, based on polysulfated glycosaminoglycans, represents a major therapeutic advance and actively contributes to maintaining and improving the locomotor well-being of horses, a central focus of equine veterinary medicine.
This reintroduction is fully aligned with our mission: to respond precisely and responsibly to equine health issues, while supporting those who care for them. Innovating, supporting and sustainably improving the quality of animal life remain at the heart of our priorities.
